FZD9 and myelodysplastic syndrome: Furthermore, significantly more genes were methylated in RAEB/AML samples than in MDS or controls, including the independent prognostic marker frizzled-9 (FZD9), a Wnt/beta-catenin signaling receptor predictive of decreased survival in MDS/AML patients when methylated.